{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:41:25Z","timestamp":1770392485617,"version":"3.49.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"SASTRA Deemed University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gene.2018.08.022","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T02:31:39Z","timestamp":1533695499000},"page":"302-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer"],"prefix":"10.1016","volume":"678","author":[{"given":"Janaki Ramaiah","family":"M.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishnave","family":"S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gene.2018.08.022_bb0005","doi-asserted-by":"crossref","first-page":"29231","DOI":"10.1074\/jbc.271.46.29231","article-title":"EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells","volume":"271","author":"Ahmed","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.08.022_bb0010","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/cdd.2009.85","article-title":"Targeted depletion of BMI1 sensitizes tumor cells to p53-mediated apoptosis in response to radiation therapy","volume":"16","author":"Alajez","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2018.08.022_bb0015","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/hmg\/2.10.1597","article-title":"Characterization and chromosomal localization of the human proto-oncogene BMi1","volume":"2","author":"Alkema","year":"1993","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2009.02.019","article-title":"Development of the pan-HDAC inhibitor panobinostat (LBH589): successes and challenges","volume":"280","author":"Atadja","year":"2009","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.gene.2018.08.022_bb0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbagrm.2016.06.002","article-title":"MDR1 mediated chemo-resistance: BMI1 and TIP60 in action","volume":"1859","author":"Banerjee","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2018.08.022_bb0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.gene.2018.08.022_bb0035","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4161\/cc.9.13.12147","article-title":"The polycomb group protein BMI is a transcriptional target of HDAC inhibitors","volume":"9","author":"Bommi","year":"2010","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.gene.2018.08.022_bb0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/hupa.2002.124721","article-title":"Reduced expression of PTEN correlates with breast cancer progression","volume":"33","author":"Bose","year":"2002","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.gene.2018.08.022_bb0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.onc.1209026","article-title":"Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression","volume":"25","author":"Bossi","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.gene.2018.08.022_bb0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.stem.2017.04.008","article-title":"Joining Forces: Bmi1 inhibition and cisplatin curb Squamous carcinogenesis","volume":"20","author":"Brown","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.gene.2018.08.022_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.04.002","article-title":"Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1, 2, 4-oxadiazole moiety as potent histone deacetylase inhibitors","volume":"96","author":"Cai","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.gene.2018.08.022_bb0060","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/jcb.23234","article-title":"BMI1 as a novel target for drug discovery in cancer","volume":"112","author":"Cao","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.gene.2018.08.022_bb0065","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/jcp.24863","article-title":"The synergistic effect of SAHA and parthenolide in MDA-MB-231 breast cancer cells","volume":"230","author":"Carlisi","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.gene.2018.08.022_bb0070","article-title":"Overexpressed miR-128a enhances chemoradiotherapy to laryngeal cancer cells and its correlation with BMI1","author":"Chen","year":"2017","journal-title":"Future Oncol."},{"issue":"44","key":"10.1016\/j.gene.2018.08.022_bb0075","doi-asserted-by":"crossref","first-page":"76057","DOI":"10.18632\/oncotarget.18648","article-title":"Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem\/progenitor cells","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.gene.2018.08.022_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076340","article-title":"Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer In vitro and In vivo","volume":"8","author":"Chiu","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.gene.2018.08.022_bb0085","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1074\/jbc.M114.624361","article-title":"MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence","volume":"290","author":"Cho","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.08.022_bb0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-1-4939-1804-1_25","article-title":"Use of epigenetic modulators as a powerful adjuvant for breast cancer therapies","volume":"1238","author":"Claude-Taupin","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.gene.2018.08.022_bb0095","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7150\/ijbs.8097","article-title":"MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma","volume":"10","author":"Dang","year":"2014","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.gene.2018.08.022_bb0100","first-page":"117","article-title":"Screening of trichostatin analogues based on cellular potency in the murine multiple myeloma 5T33MM model","volume":"4","author":"Deleu","year":"2008","journal-title":"J. Cancer Mol."},{"issue":"3","key":"10.1016\/j.gene.2018.08.022_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/iep.12177","article-title":"MiR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1","volume":"97","author":"Deng","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"issue":"7","key":"10.1016\/j.gene.2018.08.022_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.3880371","article-title":"Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer","volume":"14","author":"Depowski","year":"2001","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gene.2018.08.022_bb0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2669","article-title":"Transcriptional regulation by polycomb group proteins","volume":"20","author":"Di Croce","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1389450114666140106100909","article-title":"Therapeutic targeting of cancers with loss PTEN function","volume":"15","author":"Dillon","year":"2014","journal-title":"Curr. Drug Targets"},{"issue":"24","key":"10.1016\/j.gene.2018.08.022_bb0125","doi-asserted-by":"crossref","first-page":"36220","DOI":"10.18632\/oncotarget.8811","article-title":"A miR-200c\/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells","volume":"7","author":"Dimri","year":"2016","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.gene.2018.08.022_bb0130","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1158\/0008-5472.CAN-07-6152","article-title":"BMI-1 promotes Ewing sarcoma tumorigenicity independent of CDK2A-repression","volume":"68","author":"Douglas","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1476-4598-8-98","article-title":"PTEN inhibits BMI1 function independently of its phosphatase activity","volume":"8","author":"Fan","year":"2009","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0140","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.18632\/oncotarget.23414","article-title":"Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1","volume":"9","author":"Fesler","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2018.08.022_bb0145","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/j.oraloncology.2009.05.563","article-title":"PTEN\/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells","volume":"45","author":"Gan","year":"2009","journal-title":"Oral Oncol."},{"issue":"4","key":"10.1016\/j.gene.2018.08.022_bb0150","first-page":"1112","article-title":"Expression of BMI-1 protein in cervical, breast and ovarian cancer","volume":"116","author":"Gavrilescu","year":"2012","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi."},{"key":"10.1016\/j.gene.2018.08.022_bb0155","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI23412","article-title":"Microarray analysis identifies a death-from cancer signature predicting therapy failure in patients with multiple types of cancer","volume":"115","author":"Glinsky","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0160","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.yexcr.2017.11.039","article-title":"MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1","volume":"362","author":"Gong","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0165","doi-asserted-by":"crossref","first-page":"13343","DOI":"10.1038\/ncomms13343","article-title":"BMI1 regulates PRC1 architecture and activity through homo- and hetero-oligomerization","volume":"7","author":"Gray","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2018.08.022_bb0170","first-page":"49","volume":"485","author":"Grayson","year":"2012","journal-title":"Breast Cancer Nat."},{"issue":"4","key":"10.1016\/j.gene.2018.08.022_bb0175","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.3892\/or.2017.5478","article-title":"Silencing Bmi1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy","volume":"37","author":"Griffith","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-4598-10-10","article-title":"Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer","volume":"10","author":"Guo","year":"2011","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2013.10.034","article-title":"C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells","volume":"441","author":"Guo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"51","key":"10.1016\/j.gene.2018.08.022_bb0195","doi-asserted-by":"crossref","first-page":"42695","DOI":"10.1074\/jbc.M112.387761","article-title":"MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network","volume":"287","author":"Haga","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.08.022_bb0200","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2119\/molmed.2012.00304","article-title":"MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by down-regulating BMI1 polycomb ring finger oncogene","volume":"18","author":"He","year":"2013","journal-title":"Mol. Med."},{"issue":"20","key":"10.1016\/j.gene.2018.08.022_bb0205","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1038\/onc.2016.439","article-title":"MUC1-C activates BMI1 in human cancer cells","volume":"36","author":"Hiraki","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2018.08.022_bb0210","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1096\/fj.11-185033","article-title":"MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas","volume":"25","author":"Huang","year":"2011","journal-title":"FASEB J."},{"issue":"6715","key":"10.1016\/j.gene.2018.08.022_bb0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"Jacobs","year":"1999","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gene.2018.08.022_bb0220","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm.4415","article-title":"Targeting glioma stem cells through combined BMI1 and EZH2 inhibition","volume":"23","author":"Jin","year":"2017","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.gene.2018.08.022_bb0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.12998\/wjcc.v2.i12.769","article-title":"New targeted therapies for breast cancer: a focus on tumor environmental signals and chemo-resistant breast cancers","volume":"2","author":"Kamdje","year":"2014","journal-title":"World J. Clin. Cases"},{"issue":"17","key":"10.1016\/j.gene.2018.08.022_bb0230","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/ol035056n","article-title":"Phosphorous-based SAHA analogues as histone deacetylase inhibitors","volume":"5","author":"Kapustin","year":"2003","journal-title":"Org. Lett."},{"issue":"5","key":"10.1016\/j.gene.2018.08.022_bb0235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.prp.2018.03.020","article-title":"Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women","volume":"214","author":"Khan","year":"2018","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12272-009-1113-5","article-title":"Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues","volume":"32","author":"Kim","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2018.08.022_bb0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2010.12.005","article-title":"Non-genomic loss of PTEN function in cancer: not in my genes","volume":"32","author":"Lesile","year":"2011","journal-title":"Trends Pharmacol."},{"key":"10.1016\/j.gene.2018.08.022_bb0255","first-page":"2124","article-title":"TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta","volume":"57","author":"Li","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0260","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.gene.2018.08.022_bb0265","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/labinvest.2014.123","article-title":"Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer","volume":"94","author":"Li","year":"2014","journal-title":"Lab. Investig."},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0270","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1159\/000478069","article-title":"MiR-495 promotes senescence of mesenchymal stem cells by targeting Bmi-1","volume":"42","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.gene.2018.08.022_bb0275","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.gene.2018.08.022_bb0280","first-page":"682","article-title":"Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation","volume":"7","author":"Lukacs","year":"2010","journal-title":"Cancer Stem Cell"},{"issue":"7","key":"10.1016\/j.gene.2018.08.022_bb0285","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317718414","article-title":"MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1oncogene","volume":"39","author":"Luo","year":"2017","journal-title":"Tumor Biol."},{"issue":"22","key":"10.1016\/j.gene.2018.08.022_bb0290","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-triphosphate","volume":"273","author":"Machema","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"39","key":"10.1016\/j.gene.2018.08.022_bb0295","doi-asserted-by":"crossref","first-page":"42258","DOI":"10.18632\/oncotarget.5546","article-title":"A Polycomb-mir200 loop regulates clinical outcome in bladder cancer","volume":"6","author":"Martinez-Fernandez","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0300","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lungcan.2012.02.015","article-title":"ShRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis","volume":"77","author":"Meng","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.gene.2018.08.022_bb0305","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/onc.2015.293","article-title":"PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition","volume":"35","author":"Meng","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13058-015-0534-y","article-title":"Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple negative breast cancer cells","volume":"17","author":"Min","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"9","key":"10.1016\/j.gene.2018.08.022_bb0315","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/jid.2009.79","article-title":"PTEN: new insights into its regulation and function in skin cancer","volume":"129","author":"Ming","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.gene.2018.08.022_bb0320","first-page":"1157","article-title":"PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors","volume":"31","author":"Noro","year":"2007","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.gene.2018.08.022_bb0325","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/cncr.22585","article-title":"Histone deacetylase inhibitor trichostatin A potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression","volume":"109","author":"Pan","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.gene.2018.08.022_bb0330","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/1471-2407-14-785","article-title":"Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog","volume":"14","author":"Paranjape","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2018.08.022_bb0335","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.lfs.2016.08.028","article-title":"MiR-15a\/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1","volume":"164","author":"Patel","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0605","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1038\/s41598-017-12314-6","article-title":"MiR-15a\/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin","volume":"7","author":"Patel","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190245","article-title":"Regulating BMI1 expression via miRNAs promotes Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug","volume":"13","author":"Patel","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0345","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12253-016-0113-2","article-title":"MiRNA-429 inhibits astrocytoma proliferation and invasion by targeting BMI1","volume":"23","author":"Peng","year":"2017","journal-title":"Pathol. Oncol. Res."},{"issue":"11","key":"10.1016\/j.gene.2018.08.022_bb0350","doi-asserted-by":"crossref","first-page":"20004","DOI":"10.3390\/ijms151120004","article-title":"Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma","volume":"15","author":"Qi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2018.08.022_bb0355","article-title":"MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells","author":"Rajabi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2018.08.022_bb0360","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10549-014-2979-6","article-title":"Suppression of triple negative breast cancer metastasis by pan-DAC inhibitor panobinostat via EMT master regulators","volume":"145","author":"Rhodes","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.gene.2018.08.022_bb0365","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-013-2784-7","article-title":"Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-Cadherin","volume":"143","author":"Shah","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"48","key":"10.1016\/j.gene.2018.08.022_bb0370","doi-asserted-by":"crossref","first-page":"78813","DOI":"10.18632\/oncotarget.12385","article-title":"miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3","volume":"7","author":"Shan","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0375","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.2002.6662","article-title":"Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region","volume":"292","author":"Sheng","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.gene.2018.08.022_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060664","article-title":"BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: Regulates TCF4-transcriptional factor-induced BCL2 signaling","volume":"8","author":"Siddique","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gene.2018.08.022_bb0385","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/bcr1760","article-title":"Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients","volume":"9","author":"Silva","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0390","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm2763","article-title":"Mechanisms of polycomb gene silencing: Knowns and unknowns","volume":"10","author":"Simon","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.gene.2018.08.022_bb0395","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1172\/JCI39374","article-title":"The polycomb group protein Bmi1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells","volume":"119","author":"Song","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.gene.2018.08.022_bb0400","first-page":"2881","article-title":"Loss of PTEN promotes tumor development in malignant melanoma","volume":"63","author":"Stahl","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0600","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB \/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0405","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2018.08.022_bb0410","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.gene.2018.08.022_bb0415","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrurol.2016.131","article-title":"Prostate cancer: Inhibiting initiation - targeting BMI1 is effective","volume":"13","author":"Stone","year":"2016","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.gene.2018.08.022_bb0420","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/onc.2011.263","article-title":"MiR-200b and miR-15b regulate chemotherapy induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1","volume":"31","author":"Sun","year":"2012","journal-title":"Oncogene"},{"issue":"41","key":"10.1016\/j.gene.2018.08.022_bb0425","article-title":"Targetting MUC1-C suppresses polycomb repressive complex1 in multiple myeloma","volume":"8","author":"Tagade","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.gene.2018.08.022_bb0430","article-title":"Thiol-based SAHA analogues as potent histone deacetylase inhibitors","volume":"14","author":"Takayoshi","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.gene.2018.08.022_bb0435","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr3192","article-title":"Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat","volume":"14","author":"Tate","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0440","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1046\/j.0022-202x.2001.01954.x","article-title":"Activation of a cryptic splice site of PTEN and loss of heterozygosity in benign skin lesions in Cowden disease","volume":"117","author":"Trojan","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.gene.2018.08.022_bb0445","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2004.08.005","article-title":"Stem cells and cancer: the polycomb connection","volume":"118","author":"Valk-Lingbeek","year":"2004","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.gene.2018.08.022_bb0450","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/nar\/gkm099","article-title":"Cancer-derived p53 mutants suppress p53-target gene expression-potential mechanism for gain of function of mutant p53","volume":"35","author":"Vikhanskaya","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0455","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ncb1201-1124","article-title":"The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling","volume":"3","author":"Virolle","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2018.08.022_bb0460","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/febs.12299","article-title":"Sp1 and C-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma","volume":"280","author":"Wang","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.gene.2018.08.022_bb0465","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.21358","article-title":"Polycomb group (PcG) proteins and human cancers: multifaceted functions and therapeutic implications","volume":"35","author":"Wang","year":"2015","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0470","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-016-0323-9","article-title":"Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAs","volume":"9","author":"Wang","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.gene.2018.08.022_bb0475","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00204-014-1435-z","article-title":"Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract","volume":"90","author":"Wang","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.gene.2018.08.022_bb0480","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12935-017-0481-z","article-title":"Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma","volume":"17","author":"Wang","year":"2017","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.gene.2018.08.022_bb0485","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ncb1998","article-title":"The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs","volume":"11","author":"Wellner","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2018.08.022_bb0490","first-page":"5808","article-title":"PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death","volume":"59","author":"Weng","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2018.08.022_bb0495","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/CS20160026","article-title":"Prostate cancer, PI3K, PTEN and prognosis","volume":"131","author":"Wise","year":"2017","journal-title":"Clin. Sci."},{"issue":"5","key":"10.1016\/j.gene.2018.08.022_bb0500","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.3892\/mmr.2016.5832","article-title":"miR-203 inhibits cell growth and regulates G1\/S transition by targeting Bmi-1 in myeloma cells","volume":"14","author":"Wu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"14","key":"10.1016\/j.gene.2018.08.022_bb0505","doi-asserted-by":"crossref","first-page":"18684","DOI":"10.18632\/oncotarget.7629","article-title":"Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2018.08.022_bb0510","doi-asserted-by":"crossref","first-page":"41838","DOI":"10.1038\/srep41838","article-title":"Intestinal cancer stem cells marked by Bmi1 or Lgr5 expression contribute to tumor propagation via clonal expansion","volume":"7","author":"Yanai","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.gene.2018.08.022_bb0610","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clbc.2016.05.006","article-title":"Panitumumab, Gemcitabine, and Carboplatin as treatment for women with metastatic triple-negative breast cancer: a Sarah Cannon Research Institute Phase II Trial","volume":"16","author":"Yardley","year":"2016","journal-title":"Clin. Breast Cancer"},{"issue":"9","key":"10.1016\/j.gene.2018.08.022_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073268","article-title":"A Bmi-1 mRNAs cross-talk modulates chemotherapy response to 5-Fluorouracil in breast cancer cells","volume":"8","author":"Yin","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.gene.2018.08.022_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073268","article-title":"A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells","volume":"8","author":"Yin","year":"2013","journal-title":"PLoS One"},{"issue":"May 8","key":"10.1016\/j.gene.2018.08.022_bb0525","article-title":"A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0530","first-page":"70","article-title":"Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues","volume":"30","author":"Zhang","year":"2008","journal-title":"Exp. Oncol."},{"issue":"5","key":"10.1016\/j.gene.2018.08.022_bb0535","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.3892\/mmr.2017.7347","article-title":"Overexpression of Bmi 1 promotes epithelial mesenchymal transition in CD133+Hep G2 cells","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.gene.2018.08.022_bb0540","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41467-018-02863-3","article-title":"Bmi1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918308722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918308722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:24:30Z","timestamp":1571703870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918308722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":110,"alternative-id":["S0378111918308722"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.022","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}